Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8973 |
High Similarity |
NPD1653 |
Approved |
0.8671 |
High Similarity |
NPD7266 |
Discontinued |
0.8298 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8199 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8101 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8086 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8037 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8013 |
Intermediate Similarity |
NPD37 |
Approved |
0.7988 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7988 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7975 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7975 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7975 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7899 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7892 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7877 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7844 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.773 |
Intermediate Similarity |
NPD1091 |
Approved |
0.773 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7727 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7703 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7679 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7669 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7603 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7593 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7534 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.75 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.747 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7431 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7425 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7361 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7355 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD228 |
Approved |
0.7314 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7314 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7314 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.731 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7297 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7279 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7268 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7256 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7254 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7237 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7195 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7181 |
Intermediate Similarity |
NPD9494 |
Approved |
0.717 |
Intermediate Similarity |
NPD5297 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7089 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.708 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7078 |
Intermediate Similarity |
NPD2492 |
Phase 1 |
0.7078 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7076 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7048 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7041 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7013 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD3686 |
Approved |
0.6994 |
Remote Similarity |
NPD3687 |
Approved |
0.6988 |
Remote Similarity |
NPD7819 |
Suspended |
0.6983 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD5494 |
Approved |
0.6975 |
Remote Similarity |
NPD1512 |
Approved |
0.6962 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD6799 |
Approved |
0.695 |
Remote Similarity |
NPD969 |
Suspended |
0.6948 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6948 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6937 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.6933 |
Remote Similarity |
NPD5403 |
Approved |
0.6932 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6928 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6928 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6918 |
Remote Similarity |
NPD4237 |
Approved |
0.6918 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6914 |
Remote Similarity |
NPD2533 |
Approved |
0.6914 |
Remote Similarity |
NPD2532 |
Approved |
0.6914 |
Remote Similarity |
NPD2534 |
Approved |
0.6903 |
Remote Similarity |
NPD1933 |
Approved |
0.6901 |
Remote Similarity |
NPD7843 |
Approved |
0.6899 |
Remote Similarity |
NPD5763 |
Approved |
0.6899 |
Remote Similarity |
NPD5762 |
Approved |
0.6893 |
Remote Similarity |
NPD8312 |
Approved |
0.6893 |
Remote Similarity |
NPD8313 |
Approved |
0.6892 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD7157 |
Approved |
0.6875 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6871 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6853 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.6849 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6848 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6839 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6835 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6835 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6824 |
Remote Similarity |
NPD919 |
Approved |
0.681 |
Remote Similarity |
NPD5401 |
Approved |
0.6807 |
Remote Similarity |
NPD4675 |
Approved |
0.6807 |
Remote Similarity |
NPD4678 |
Approved |
0.68 |
Remote Similarity |
NPD4749 |
Approved |
0.6795 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6795 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6792 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6792 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6786 |
Remote Similarity |
NPD5773 |
Approved |
0.6786 |
Remote Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.6786 |
Remote Similarity |
NPD5772 |
Approved |
0.6776 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6774 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.677 |
Remote Similarity |
NPD3750 |
Approved |
0.677 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6768 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6766 |
Remote Similarity |
NPD6385 |
Approved |
0.6766 |
Remote Similarity |
NPD6386 |
Approved |
0.6766 |
Remote Similarity |
NPD7411 |
Suspended |
0.6763 |
Remote Similarity |
NPD5242 |
Approved |
0.6757 |
Remote Similarity |
NPD4626 |
Approved |
0.6753 |
Remote Similarity |
NPD7095 |
Approved |
0.675 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6738 |
Remote Similarity |
NPD2684 |
Approved |
0.6735 |
Remote Similarity |
NPD9545 |
Approved |
0.6731 |
Remote Similarity |
NPD1558 |
Phase 1 |
0.673 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6728 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6719 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6709 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6708 |
Remote Similarity |
NPD3060 |
Approved |
0.6707 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6707 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6706 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6705 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6689 |
Remote Similarity |
NPD5691 |
Approved |
0.6689 |
Remote Similarity |
NPD9268 |
Approved |
0.6687 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD291 |
Approved |
0.6667 |
Remote Similarity |
NPD290 |
Approved |
0.6667 |
Remote Similarity |
NPD5588 |
Approved |
0.6667 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6647 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6647 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6645 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6644 |
Remote Similarity |
NPD1778 |
Approved |
0.6644 |
Remote Similarity |
NPD5126 |
Approved |
0.6644 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6644 |
Remote Similarity |
NPD6671 |
Approved |
0.6632 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6627 |
Remote Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.6624 |
Remote Similarity |
NPD4140 |
Approved |
0.6624 |
Remote Similarity |
NPD1240 |
Approved |
0.6606 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6606 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6605 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6604
|
Remote Similarity |
NPD4538 |
Approved |